Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mutsumi Hayashi
CD26 Is a Potential Therapeutic Target by Humanized Monoclonal Antibody for the Treatment of Multiple Myeloma
Blood Cancer Journal
Oncology
Hematology
Related publications
RSK2Ser227 at N-Terminal Kinase Domain Is a Potential Therapeutic Target for Multiple Myeloma
Molecular Cancer Therapeutics
Cancer Research
Oncology
TRAF6 Activation in Multiple Myeloma: A Potential Therapeutic Target
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
FOXM1 Is a Therapeutic Target in High-Risk Multiple Myeloma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Therapeutic Targeting of N-Cadherin Is an Effective Treatment for Multiple Myeloma
British Journal of Haematology
Hematology
Therapeutic Potential of AO-176, a Next Generation Humanized CD47 Antibody, for Hematologic Malignancies
Blood
Biochemistry
Immunology
Cell Biology
Hematology
EZH2 as a Therapeutic Target for Multiple Myeloma and Other Haematological Malignancies
Biomarker Research
Biochemistry
Molecular Medicine
Clinical Biochemistry
The Therapeutic Potential of Cell Cycle Targeting in Multiple Myeloma
Oncotarget
Oncology
The Therapeutic Monoclonal Antibody Market
mAbs
Allergy
Immunology
Current Use of Monoclonal Antibodies in the Treatment of Multiple Myeloma
British Journal of Haematology
Hematology